| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $201.0M | +2.1% | +9.3% |
| Cost of Revenue | $22.3M | +10.3% | +12.7% |
| Gross Profit | $178.7M | +1.1% | +8.9% |
| R&D Expense | $73.8M | -7.0% | -11.4% |
| SG&A Expense | $74.7M | +86.1% | +105.8% |
| Operating Income | -$70.0M | -41.5% | -16.3% |
| Pre-tax Income | -$67.1M | -43.0% | -19.5% |
| Income Tax | $1.3M | -8.8% | +11.0% |
| Net Income | -$68.4M | -41.5% | -19.4% |
| EPS (Basic) | -$0.29 | -45.0% | -16.0% |
| EPS (Diluted) | -$0.29 | -45.0% | -16.0% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $183.5M | -0.4% | -6.8% |
| Accounts Receivable | $72.3M | +4.4% | +8.1% |
| Current Assets | $587.4M | -1.9% | +2.8% |
| Total Assets | $840.4M | -4.8% | -3.9% |
| Current Liabilities | $420.9M | -0.7% | +9.9% |
| Total Liabilities | $652.1M |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $62.8M | — | — |
| Capital Expenditures | $2.6M | — | — |
| Investing Cash Flow | -$5.5M | — | — |
| Financing Cash Flow | -$62.1M | — | — |
| Free Cash Flow | $60.2M | — | — |
| +2.7% |
| Stockholders' Equity | $188.4M | -16.1% | -21.3% |